Anxiety in Children and Adolescents - 1.5 pages
smartswan- Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating anxiety disorder in children and adolescents.
- Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
- Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
- Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.
4 years ago
8
Answer(1)![blurred-text]()
Purchase the answer to view it
NOT RATED
Task31.docx- Turnitinreport1.pdf
other Questions(10)
- Successful Person Bio
- To participate in the following discussions, go to this week's Discussion link in the left navigation. Lot Sizing What alternatives are there to lot-for-lot scheduling at each level? Identify and discuss the potential advantages and disadvantages of oth
- STAT200 WEEK 8 HOMEWORK A+
- Case Study Analysis PowerPoint (PPT) Presentation:
- fin homework 2
- Finance Assignment - LASA Project Planning Developing the Project Plan and Determining Critical Path
- 1
- Discussion Question
- Research Paper
- essay about the book Metamorphoses by Ovid
